Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Global impact of delta plus variant and vaccination
Vivek P. Chavda, Vasso Apostolopoulos
Expert Review of Vaccines (2022) Vol. 21, Iss. 5, pp. 597-600
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

SARS‐CoV‐2 variants and vulnerability at the global level
Vivek P. Chavda, Aayushi Patel, Darsh D. Vaghasiya
Journal of Medical Virology (2022) Vol. 94, Iss. 7, pp. 2986-3005
Open Access | Times Cited: 111
Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions
Manish Dhawan, Abhilasha Sharma, Priyanka Choudhary, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 91
The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far
Vivek P. Chavda, Rajashri Bezbaruah, Kangkan Deka, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1926-1926
Open Access | Times Cited: 75
Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status
Vivek P. Chavda, Rajashri Bezbaruah, Disha Valu, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 432-432
Open Access | Times Cited: 55
From Alpha to Omicron: How Different Variants of Concern of the SARS-Coronavirus-2 Impacted the World
Mickensone Andre, Lee-Seng Lau, Marissa D. Pokharel, et al.
Biology (2023) Vol. 12, Iss. 9, pp. 1267-1267
Open Access | Times Cited: 55
mRNA Vaccines against SARS-CoV-2: Advantages and Caveats
Miriam Echaide, Luisa Chocarro, Ana Bocanegra, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5944-5944
Open Access | Times Cited: 54
Protein subunit vaccines: Promising frontiers against COVID-19
Vivek P. Chavda, Eswara Naga Hanuma Kumar Ghali, Pankti C. Balar, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 761-782
Closed Access | Times Cited: 19
Replicating Viral Vector-Based Vaccines for COVID-19: Potential Avenue in Vaccination Arena
Vivek P. Chavda, Rajashri Bezbaruah, Mansi Athalye, et al.
Viruses (2022) Vol. 14, Iss. 4, pp. 759-759
Open Access | Times Cited: 55
Recent review of COVID-19 management: diagnosis, treatment and vaccination
Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 6, pp. 1120-1148
Open Access | Times Cited: 55
Therapeutic monoclonal antibodies for COVID-19 management: an update
Vivek P. Chavda, Riddhi Prajapati, Disha Lathigara, et al.
Expert Opinion on Biological Therapy (2022) Vol. 22, Iss. 6, pp. 763-780
Closed Access | Times Cited: 54
Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world
Vivek P. Chavda, Qian Yao, Lalitkumar K. Vora, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 47
Conventional and Novel Diagnostic Tools for the Diagnosis of Emerging SARS-CoV-2 Variants
Vivek P. Chavda, Disha Valu, Palak K. Parikh, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 374-374
Open Access | Times Cited: 30
Omicron Variant of SARS-CoV-2: An Indian Perspective of Vaccination and Management
Vivek P. Chavda, Pankti C. Balar, Dixa A. Vaghela, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 160-160
Open Access | Times Cited: 29
SARS-CoV-2 Viral Replication Persists in the Human Lung for Several Weeks after Symptom Onset
Michele Tomasicchio, Shameem Z. Jaumdally, Lindsay Wilson, et al.
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 209, Iss. 7, pp. 840-851
Open Access | Times Cited: 9
COVID-19 and vaccination: myths vs science
Vivek P. Chavda, Yangmin Chen, Jayant Dave, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 11, pp. 1603-1620
Closed Access | Times Cited: 34
2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update
Zoufang Huang, Vivek P. Chavda, Lalitkumar K. Vora, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 33
Pseudoscience and fraudulent products for COVID-19 management
Vivek P. Chavda, Shreya S. Sonak, Nafesa K. Munshi, et al.
Environmental Science and Pollution Research (2022) Vol. 29, Iss. 42, pp. 62887-62912
Open Access | Times Cited: 30
Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update
Vivek P. Chavda, Rajashri Bezbaruah, Sheetal Dolia, et al.
Process Biochemistry (2023) Vol. 127, pp. 66-81
Open Access | Times Cited: 18
Therapeutics to Tackle Omicron Outbreak
Vivek P. Chavda, Eswara Naga Hanuma Kumar Ghali, Murali M. Yallapu, et al.
Immunotherapy (2022) Vol. 14, Iss. 11, pp. 833-838
Open Access | Times Cited: 27
Potential Anti-SARS-CoV-2 Prodrugs Activated by Phosphorylation and Their Role in the Aged Population
Vivek P. Chavda, Divya Teli, Pankti C. Balar, et al.
Molecules (2023) Vol. 28, Iss. 5, pp. 2332-2332
Open Access | Times Cited: 13
Process development for an effective COVID-19 vaccine candidate harboring recombinant SARS-CoV-2 delta plus receptor binding domain produced by Pichia pastoris
Sibel Kalyoncu, Semiramis Yılmaz, Ayça Zeybek Kuyucu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Monkeypox: a new face of outbreak
Vivek P. Chavda, Lalitkumar K. Vora, Vasso Apostolopoulos
Expert Review of Vaccines (2022) Vol. 21, Iss. 11, pp. 1537-1540
Open Access | Times Cited: 18
Ayurvedic and Other Herbal Remedies for Dengue: An Update
Vivek P. Chavda, Anup Kumar, Rittwika Banerjee, et al.
Clinical Complementary Medicine and Pharmacology (2022) Vol. 2, Iss. 3, pp. 100024-100024
Open Access | Times Cited: 16
Effectiveness of SARS-CoV-2 Vaccines for Short- and Long-Term Immunity: A General Overview for the Pandemic Contrast
Alessio Danilo Inchingolo, Giuseppina Malcangi, Sabino Ceci, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8485-8485
Open Access | Times Cited: 15
Comparative Study of the Mutations Observed in the SARS-CoV-2 RBD Variants of Concern and Their Impact on the Interaction with the ACE2 Protein
Mariem Ghoula, Audrey Deyawe Kongmeneck, Rita Eid, et al.
The Journal of Physical Chemistry B (2023) Vol. 127, Iss. 40, pp. 8586-8602
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top